*** VIDEO RELEASE *** Menendez Pushes Azar to Commit to Support the CREATES Act and Explains How it Would Lower Prescription Drug Costs

*** VIDEO RELEASE *** Menendez Pushes Azar to Commit to Support the CREATES Act and Explains How it Would Lower Prescription Drug Costs

Earlier today, HHS Secretary Azar would not commit to support the CREATES Act, despite Senator Menendez explaining its bipartisan nature and how it achieves an administration goal. Menendez highlighted the positive impacts of the CREATES Act in a video explainer released on Social Media.

WASHINGTON, D.C. – U.S. Senator Bob Menendez, a senior member of the Senate Finance Committee that sets national health policy, today questioned Secretary of Health & Human Services Alex Azar about the high cost of prescription drugs, and particularly the Trump Administration’s position on the CREATES Act and the common practice of prescription drug companies not providing samples to generic drug companies so cheaper drugs become available to consumers as quickly as possible.

"One of the reasons that we are not seeing reduced prescription drug prices is because some bad actors continue to game the system to prevent cheaper drugs from coming to market,” Menendez said.  “I hope the administration can come to a formal position [on the CREATES Act] because it’s bipartisan, and it does exactly what the President’s ‘blueprint’ said he sought to do.”

Azar failed to take a position on the CREATES Act.

CLICK TO WATCH

Despite the vague responses from Azar today, Senator Menendez highlighted the positive impacts of the CREATES Act and how it would bring more generic drugs to the market, and lower prescription drug prices in a video explainer released on Social Media. 

CLICK TO WATCH ON FACEBOOK

CLICK TO WATCH ON TWITTER

Menendez is a sponsor of the CREATES Act, which cracks down on drug companies that intentionally delay the required sharing of product samples with generic manufacturers to develop generic versions of the brand-name drug.

Menendez also supports the Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act, introduced by Sen. Ron Wyden (D-Ore.), which would require pharmaceutical companies who engage in price-gouging to explain to the public their reasons for hiking the prices of their medications when those increases exceed a certain benchmark. 

###